Reata Pharmaceuticals Inc (RETA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Reata Pharmaceuticals Inc   (NASDAQ: RETA)

Reata Pharmaceuticals Inc

Officers & Directors




Executives:
- Warren Huff (Founder, President and Chief Executive Officer)
- Manmeet S. Soni (Chief Operating Officer)
- Jason D. Wilson (General Counsel and Chief Compliance Officer)
- Colin J. Meyer (Chief Financial Officer)
- R. Alden Klassen (Chief Medical Officer)
- Elaine Castellanos (Senior Vice President, Clinical Development)
- Kyle W. Buhler (Senior Vice President of Corporate Development and Strategy)
- John A. Orwin (Lead Independent Director)

Directors:
- Warren Huff (Founder, President and Chief Executive Officer)
- John Kraeutler (Independent Director)
- R. Kent McGaughy (Independent Director)
- James A. Schoeneck (Independent Director)
- Debra D. Simon (Independent Director)
- Thomas Woiwode (Independent Director)

Reata Pharmaceuticals Inc currently has 350 employees.






RETA Management Effectiveness RETA Revenue per Employee RETA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.